443 related articles for article (PubMed ID: 37402968)
21. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
23. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.
Tang C; Qin L; Li J
Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416
[TBL] [Abstract][Full Text] [Related]
24. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma.
Huang Y; Guo W; Zeng Y; Wang X; Fan B; Zhang Y; Yan L; Gu G; Liu Z
Front Oncol; 2024; 14():1354049. PubMed ID: 38454924
[TBL] [Abstract][Full Text] [Related]
26. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
27. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
Ju L; Shi Y; Liu G
PeerJ; 2022; 10():e14506. PubMed ID: 36570012
[TBL] [Abstract][Full Text] [Related]
29. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
[TBL] [Abstract][Full Text] [Related]
30. Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma.
Ding W; Zhang M; Zhang P; Zhang X; Sun J; Lin B
Sci Rep; 2023 Oct; 13(1):18069. PubMed ID: 37872217
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma.
Diao X; Guo C; Li S
Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553
[TBL] [Abstract][Full Text] [Related]
32. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
33. Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer.
Lei J; Guo G; Liang D; Gong L; Zhang L; Wang X
Biochem Biophys Res Commun; 2023 Sep; 673():137-144. PubMed ID: 37385008
[TBL] [Abstract][Full Text] [Related]
34. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
Wu Y; Li X
Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
[TBL] [Abstract][Full Text] [Related]
35. Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma.
Zhu Z; Wang Q; Zeng X; Zhu S; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3915-3933. PubMed ID: 38385949
[TBL] [Abstract][Full Text] [Related]
36. Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.
Hao C; Li R; Lu Z; He K; Shen J; Wang T; Qiu T
Front Immunol; 2023; 14():1145450. PubMed ID: 37359524
[TBL] [Abstract][Full Text] [Related]
37. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
Front Genet; 2023; 14():1186862. PubMed ID: 37323657
[No Abstract] [Full Text] [Related]
38. Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma.
Wu Q; Sun Y; Qin X; Li M; Huang S; Wang X; Weng G
Front Oncol; 2023; 13():1211103. PubMed ID: 37965453
[TBL] [Abstract][Full Text] [Related]
39. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
